HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boots

This article was originally published in The Rose Sheet

Executive Summary

Beauty and toiletries sales advanced 4.7% to $3.7 bil. (£1=$1.84), with premium cosmetics growing 10%, boosted by a strong seasonal gift program and expanded distribution, British retailer says in preliminary FY 2003 (ended March 31) results. Fragrance sales were up on new launches, Boots adds. In addition, sunshop sales increased 17%. Toiletries volume was modest, due in part to price reductions in the category, firm notes. Boots The Chemist generated sales of $8.26 bil., up 4.5% adjusted for currency, or 3.9% like-for-like. Operating profit declined 6.6% to $975 mil. Sales in Boots Healthcare International improved 9.6%, or 7.8% in local currency, to $619.7 mil. Clearasil sales were up 6% overall, but dropped 3% in the U.S. "due to substantial pipeline fill in 2002/2003," according to the retailer. Operating profit grew 15% to $148 mil. Group sales improved 5% to $9.8 bil., with group operating profit from continuing operations up 6% to $1 bil...
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS012164

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel